We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

fMRI Brain Imaging Identifies Differences in Childhood Bipolar Disorder, ADHD

By MedImaging International staff writers
Posted on 03 Nov 2010
U.S. researchers are the first to use brain imaging to examine the effects of emotion on working memory function in children with pediatric bipolar disorder (PBD) or attention deficit hyperactivity disorder (ADHD).

The study, conducted by investigators from the University of Illinois at Chicago (UIC; USA), was published in the October 2010 issue of the Journal of the American Academy of Child & Adolescent Psychiatry. PBD and ADHD are very severe developmental disorders that share behavioral characteristics such as impulsivity, irritability, and attention problems.

Using functional magnetic resonance imaging (fMRI), UIC researchers studied the brain activity of children as they performed a working memory task while viewing faces with different emotions, such as angry, happy, or neutral expressions. The children, ages 10 to 18, were asked to remember the faces and to press a button in the MR-scanner if they saw the same face that was presented two trials earlier. The study involved 23 nonmedicated children with bipolar disorder, 14 nonmedicated children with ADHD, and 19 healthy controls.

"It's a simple yet elegant working memory test that tells us a lot about how their brain remembers stimuli like faces or objects,” said Dr. Alessandra Passarotti, assistant professor of psychiatry at UIC and lead author of the study. "We also added in an emotional component--because both disorders show emotional deficits--to study how their working memory is affected by emotional challenge.”

The researchers found that while both disorders show dysfunction in the prefrontal cortex relative to healthy controls, the ADHD group had the most severe dysfunction in this significant region.

From a treatment, learning, and intervention perspective, the next step for researchers and clinicians is to figure out how to help patients use their prefrontal cortex, according to Dr. Passarotti. The researchers also discovered that while the ADHD group had greater dysfunction in working memory circuits in the brain, the bipolar group had more deficits in regions of the brain involved in emotion processing and regulation.

Now that researchers are beginning to distinguish between the two disorders at a brain network level, instead of just at a behavioral level, the long-term goal is to develop diagnostic tests based on neurologic and behavioral markers of illness that can be used in a clinical setting.

It is difficult for physicians to differentiate between the two disorders behaviorally, which may lead to an incorrect diagnosis and wrong medications, a worsening of symptoms, and greater frustration for children and parents, according to Dr. Passarotti, a researcher in UIC's Institute for Juvenile Research. She reported that that while researchers still do not understand all of the neurologic deficits that characterize ADHD and PBD profiles, they know that drug treatment that works for ADHD does not work for bipolar disorder.

"In fact, if you give a stimulant to a child with bipolar disorder, they become more manic, and this makes their illness even worse, whereas if you give the mood-regulation medicine commonly prescribed for PBD to a child with ADHD, they still show a lot of attention deficits and do not show any improvement,” Dr. Passarotti concluded. "Our hope is that by better differentiating between these two severe developmental illnesses, we can help develop more accurate diagnoses and more targeted treatments for PBD and ADHD.”

Related Links:

University of Illinois at Chicago


Gold Member
Electrode Solution and Skin Prep
Signaspray
Gold Member
Ultrasound System
FUTUS LE
Gold Member
UGPIV Barrier and Securement
UltraDrape II
X-Ray Protective Head Cap
RA611 & RA612

Latest MRI News

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
03 Nov 2010  |   MRI

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
03 Nov 2010  |   MRI

Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
03 Nov 2010  |   MRI